Simultaneously quantifying hundreds of acylcarnitines in multiple biological matrices within ten minutes using ultrahigh-performance liquid-chromatography and tandem mass spectrometry.

Authors:
Zhang J; Chen Q; Zhang L; Shi B; Yu M and 2 more

Journal:
J Pharm Anal

Publication Year: 2023

DOI:
10.1016/j.jpha.2023.10.004

PMCID:
PMC10859589

PMID:
38352947

Journal Information

Full Title: J Pharm Anal

Abbreviation: J Pharm Anal

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that there are no conflicts of interest."

Evidence found in paper:

"We acknowledge financial supports from the 10.13039/501100012166National Key R&D Program of China (Grant Nos.: 2022YFC3400700, 2022YFA0806400, and 2020YFE0201600), Shanghai Municipal Science and Technology Major Project (Grant No.: 2017SHZDZX01), and the 10.13039/501100001809National Natural Science Foundation of China (Grant No.: 31821002). Jingxian Zhang: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Data curation, Visualization, Writing - Original draft preparation; Qinsheng Chen: Validation, Formal analysis, Visualization, Writing - Original draft preparation; Lianglong Zhang: Validation, Formal analysis; Biru Shi: Validation; Men Yu: Conceptualization, Validation; Qingxia Huang: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Data curation, Visualization, Writing - Original draft preparation; Huiru Tang: Resources, Conceptualization, Methodology, Validation, Formal analysis, Investigation, Data curation, Visualization, Writing - Reviewing and Editing, Supervision, Funding acquisition, Project administration."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025